- Home
- ELVN vs INVA Comparison
ELVN vs INVA Comparison
Compare ELVN & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- INVA
- Stock Information
- Founded
- ELVN 2016
- INVA 1996
- Country
- ELVN United States
- INVA United States
- Employees
- ELVN N/A
- INVA N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- ELVN Health Care
- INVA Health Care
- Exchange
- ELVN Nasdaq
- INVA Nasdaq
- Market Cap
- ELVN 1.2B
- INVA 1.3B
- IPO Year
- ELVN 2020
- INVA 2004
- Fundamental
- Price
- ELVN $22.63
- INVA $19.07
- Analyst Decision
- ELVN Strong Buy
- INVA Buy
- Analyst Count
- ELVN 5
- INVA 2
- Target Price
- ELVN $41.20
- INVA $40.50
- AVG Volume (30 Days)
- ELVN 721.5K
- INVA 981.3K
- Earning Date
- ELVN 08-12-2025
- INVA 07-30-2025
- Dividend Yield
- ELVN N/A
- INVA N/A
- EPS Growth
- ELVN N/A
- INVA N/A
- EPS
- ELVN N/A
- INVA N/A
- Revenue
- ELVN N/A
- INVA $369,844,000.00
- Revenue This Year
- ELVN N/A
- INVA $3.75
- Revenue Next Year
- ELVN N/A
- INVA $12.62
- P/E Ratio
- ELVN N/A
- INVA N/A
- Revenue Growth
- ELVN N/A
- INVA 18.70
- 52 Week Low
- ELVN $13.30
- INVA $16.67
- 52 Week High
- ELVN $30.03
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- ELVN 60.45
- INVA 35.14
- Support Level
- ELVN $19.38
- INVA $18.92
- Resistance Level
- ELVN $21.34
- INVA $19.40
- Average True Range (ATR)
- ELVN 1.27
- INVA 0.56
- MACD
- ELVN 0.11
- INVA -0.21
- Stochastic Oscillator
- ELVN 88.47
- INVA 7.42
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.